The acquisition “will accelerate the achievement of our long-term strategic and financial goals for our industrial and healthcare materials segment,” commented Avery Dennison President and CEO Mitch Butier.
Headquartered in Longford, Ireland, Finesse Medical specializes in the development and application of advanced technologies in wound care and skin treatment, including skin barrier films and protection creams, and silicone and polyurethane foam wound dressings. The company, which reported revenue of approximately €15 million in 2016, is a key supplier to global healthcare-product OEMs and also provides contract manufacturing and product development services.
“Finesse Medical is a great strategic fit with Vancive Medical Technologies,” said Mike Johansen, Vice President and General Manager of Avery Dennison’s Industrial and Healthcare Materials group. (Vancive Medical Technologies is an Avery Dennison business headquartered in Chicago.)
“Its innovative portfolio of silicone gels and polyurethane foam dressings builds on and complements our existing products in wound care. And its converting and packaging capabilities will enable us to offer expanded manufacturing services to our customers.”
Vancive Medical, an Avery Dennison business, is among several hundred exhibitors at the co-located PLASTEC East and MD&M East event in New York City in June. Go to the PLASTEC East website to learn more about the event and to register to attend.
“Uniting our two healthcare businesses is a strategic win for both organizations and our global customer base,” said Martin Dowd, Director, Marketing & Business Development, at Finesse Medical. “Our companies share a strong commitment to quality, service and innovation.
Avery Dennison brings important new strengths to our business, including key relationships in the U.S. healthcare industry, new global sales and distribution channels for our products, and coating and roll manufacturing expertise that deepens our service offerings.”